BioElectronics Files FDA Application for Treatment of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
31
BioElectronics Files FDA Application for Treatment of Musculoskeletal Pain

FREDERICK, MD, July 12, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that a Traditional 510(k) Premarket Notification for ActiPatch® was filed today with the U.S. Food and Drug Administration (FDA). The market clearance requested was “ over-the-counter adjunctive use in the treatment of musculoskeletal pain ”.

While ActiPatch is already FDA-cleared for adjunctive treatment of pain from knee osteoarthritis (25 million) and plantar fasciitis (2 million annually), expanded market clearance would allow additional products for the back (42 million), neck (19 million), hip (9 million), shoulder (11 million), carpal tunnel (12 million) and many other musculoskeletal complaints. Full details about the study can be found at the NIH’s clinical trials listing page: ( NIH Back Pain study link ).

The 510(k) was prepared by the R&D team comprising: Kenneth McLeod, Ph.D., Director of Clinical Science and Engineering Research, State University of New York at Binghamton and Richard Staelin, Ph.D., Gregory Mario and Jeremy Mario Professor, Duke University, Ian Rawe, Director of Clinical Research, BioElectronics and Sree Koneru, Ph.D., VP Product Development, BioElectronics. Dr. Koneru, who spearheaded the 510(k) effort, said, “We are confident with the strength of our data and overall application. Given the FDA’s prior knowledge of the data and prior clearances, we believe that the 510(k) will be processed in a timely manner.”

Keith Nalepka, VP of Sales/Marketing, remarked on the market opportunity: “An expanded market clearance will make ActiPatch available as a drug-free, safe, pain relief option for the 126 million Americans (one in two adults) who are suffering with musculoskeletal pain.”

About BioElectronics Corporation

BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy. For more information, please visit  www.tryactipatch.com

Paul Knopick 9402623584 pknopick@eandecommunications.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s Second IND Adds Proof to Its Glue Platform

Updated Category News Views 25

Two IND acceptances from one long-running alliance is not nothing, especially in a drug-discovery business where plenty of polished platform talk never makes it to the clinic. Evotec has cleared that modest but meaningful bar again with Bristol Myers Squibb: a second molecular-glue candidate has received FDA acceptance for an Investigational New Drug application. The...

Continue Reading
Fidelis Puts $140,000 Behind Statewide Postpartum Care

Updated Category News Views 125

A missed postpartum appointment can look like a small administrative failure until it is not. Fidelis Care’s $140,000 round of Here for Your Health maternal health grants is aimed squarely at that unglamorous but consequential gap: keeping new mothers connected to care after delivery, particularly in underserved New York communities. Small Dollars, Very Specific...

Continue Reading
Miami I20 Tests Appetite for Long-Term U.S. Capital

Updated Category News Views 154

Five days in a Miami airport hotel may not sound like the machinery of national investment policy, yet the guest list for the inaugural I20 Summit is serious enough to make capital markets sit up. From December 11 through 15, the Sovereign Wealth Fund Institute plans to bring sovereign funds, pensions, endowments, family offices, business leaders and U.S....

Continue Reading
WeWalk Brings Diabetes Support Back to Dubai Science Park

Updated Category News Views 32

Before sunrise on 21 November, a 3.5 km route in Dubai Science Park will carry a purpose bigger than sneakers and weekend fitness. WeWalk is returning for its seventh edition, with TECOM Group PJSC and Dubai Charity Association again putting the event behind support for children living with diabetes. That deserves to be said plainly: this is a community health effort, not...

Continue Reading
Weatherford Adds Grant Roach to Its Sports Deal Team

Updated Category News Views 69

Sports investing has reached that awkward middle age where everybody sees the runway, but few can explain exactly where the bumps are. Weatherford Capital’s decision to bring Grant Roach aboard as vice president is not a headline packed with transaction fireworks. It is, however, a pretty clear tell: the Tampa firm intends to put more bodies and more underwriting muscle...

Continue Reading
Travelzoo Turns Thanksgiving Delays Into Member Value

Updated Category News Views 108

Airport gridlock is a miserable place to make a membership pitch, yet Travelzoo has found a pretty shrewd angle for it. On November 18, the company said nearly 20 million travelers will move through airports during the upcoming Thanksgiving holiday, when cancellations and delays can turn an ordinary trip into a long, fluorescent-lit slog. Its offer: qualifying Club...

Continue Reading
Layne’s Jacksonville Debut Tests East Texas Expansion

Updated Category News Views 57

Jacksonville is not some flashy coastal launch, and that is precisely why this Layne’s Chicken Fingers opening matters. A new chicken tender shop at 1217 S. Jackson St. will not move public markets, because this is a franchise-growth story rather than a ticker story. But it does offer a clean look at whether Layne’s can turn its Texas roots into a durable multi-market...

Continue Reading
Adecco Finds AI Value Depends on Better Work Redesign

Updated Category News Views 39

A shiny AI license is not a productivity strategy, and Adecco's latest workforce survey puts some hard numbers behind that irritation. The company surveyed 40,500 workers in 36 countries for its seventh Global Workforce of the Future report, released November 19, 2026. Its central finding is disarmingly sensible: AI produces more when companies rebuild the work around it...

Continue Reading
CHN Energy's Indonesia Record Deserves a Hard Look

Updated Category News Views 50

Twenty years of boots sinking into swamp mud tells a sturdier story than a polished anniversary slogan. CHN Energy says it entered Indonesia's energy market two decades ago and has since built an operating presence around reliable electricity, local training and community work. In a country scattered across thousands of islands, dependable power is not some decorative...

Continue Reading
Vector's Peptide Pact Needs Proof Before Any Payday

Updated Category News Views 194

A famous orthopedic name can open doors, but it cannot manufacture clinical evidence. That is the plain reality behind Vector Science and Therapeutics' new collaboration with the Andrews Research & Education Foundation. Dr. James Andrews carries enormous credibility in sports medicine, earned across more than five decades of work. For Vector, that association matters. For...

Continue Reading

Top 5 Most Recently Viewed Articles

Appian Partners with Children's National to Elevate Healthcare

Updated Category News Views 87

Appian Teams Up with Children’s National Hospital Appian, known for its cutting-edge software solutions, is excited to share its new collaboration with Children’s National Hospital, one of the top names in pediatric healthcare. This partnership aims to raise awareness and gather essential resources for children's health. Appian is dedicated to enhancing the healthcare...

Continue Reading
Deutsche Bank Predicts ECB Rate Cuts Amid Falling Inflation

Updated Category News Views 101

Deutsche Bank dropped a prediction back in late 2023 that the European Central Bank (ECB) was gearing up for interest rate cuts this October. Traders perked up when they caught wind of unexpected dips in inflation figures from the eurozone noted earlier that September. Why the Cut? Inflation Insights Unpacked Analysts at Deutsche Bank, led by chief economist Mark Wall,...

Continue Reading
Vipshop's Financial Performance Analysis for 2024 Revealed

Updated Category News Views 390

Vipshop's Financial Insights for 2024 Vipshop Holdings Limited (NYSE: VIPS), a prominent online discount retailer in the Chinese market, has recently shared its unaudited financial results for the quarter and full year that concluded on December 31, 2024. Despite encountering challenges over the previous year, Vipshop's performance indicates resilience and potential...

Continue Reading
Boston University and Infocap Partner for Digital Transformation

Updated Category News Views 207

Boston University's Digital Business Institute Partners with Infocap BOSTON--The Digital Business Institute (DBI) at Boston University Questrom School of Business and Infocap AI Corp, a leader in human-centric automation, have announced a strategic partnership aimed at revolutionizing digital transformation across the banking sector. This collaboration is particularly...

Continue Reading
Disclosure and Investment Position Overview for Keywords Studios

Updated Category News Views 116

Understanding Disclosure and Investment Positions In the complex world of stock market investments, transparency is crucial. This is especially true for organizations involved with Keywords Studios PLC, a leading player in the gaming services sector. This article seeks to shed light on the recent disclosures and key investments associated with this prominent company. Key...

Continue Reading